Can ACE Inhibitors Promote Detrimental Vascular Effects After Percutaneous Injury?
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D006083:Graft Occlusion, Vascular / Q000000981:diagnostic imaging / Q000209:etiology* / Q000378:metabolism; D006801:Humans; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D011859:Radiography; D044140:Receptor, Angiotensin, Type 1; D011945:Receptors, Angiotensin / Q000096:biosynthesis; D015607:Stents / Q000009:adverse effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D044140:Receptor, Angiotensin, Type 1; D011945:Receptors, Angiotensin; D007703:Peptidyl-Dipeptidase A